Gender | Age | Diagnosis | Site of tumour | Staging | Minimum margin | Margin | Necrosis |
---|---|---|---|---|---|---|---|
M | 48 | Myxoid liposarcoma | Right knee | T2bN0M0 | 1 mm | Negative | 100% |
F | 41 | Myxoid liposarcoma | Left leg ant/lat | T2bN0M0 | 0.5 mm | Negative | |
M | 83 | Myxofibrosarcoma | Right forearm/wrist | T1aN0M0 | 2 mm | Negative | 98% |
F | 57 | Malignant fibrous tumour | Right popliteal fossa | T2bN0M0 | 1 mm | Negative | |
F | 42 | Myxoid liposarcoma | Right popliteal fossa | T2bN0M0 | >5 mm | Negative | 95% |
M | 57 | Extraskeletal myxoid chondrosarcoma | Left wrist/forearm | T1bN0M0 | 0.5 mm | Negative | |
M | 54 | Myxoid liposarcoma | Left calf/ankle | T2bN0M0 | 2 mm | Negative | 100% |
M | 31 | Sclerosing epithelioid fibrosarcoma | Left medial knee/thigh | T2bN0M0 | 1 mm | Negative | |
M | 59 | Extraskeletal myxoid chondrosarcoma | Left knee | T2bN0M0 | 0.5 mm | Negative | |
M | 50 | Synovial sarcoma | Left thigh/knee | T2bN0M0 | 0 mm | Positive | 75% |
M | 31 | Pleomorphic liposarcoma | Left anterior thigh/knee | T2bN0M0 | 3 mm | Negative | 0% |
F | 77 | Spindle cell sarcoma | Left wrist/forearm | T2bN0M0 | 3 mm | Negative | 99% |
F | 37 | Leiomyosarcoma | Right triceps/elbow | T2bN0M0 | 0.5 mm | Negative | 50% |
M | 46 | Myxoid liposarcoma | Left posterior knee/thigh | T2bN0M0 | 1 mm | Negative | 100% |
M | 54 | Pleomorphic myxofibrosarcoma | Right elbow | T2bN0M0 | >5 mm | Negative | 100% |
F | 75 | Pleomorphic sarcoma | Left lateral shoulder | T2bN0M0 | >3 mm | Negative | 50% |
F | 51 | Myxoid liposarcoma | Right posteromedial thigh | T2bN0M0 | 1 mm | Negative |